Description
VetriGel Wound Dressing is indicated for the management of wounds. The product provides moisture to the wound, physical protection, and a barrier against microbial contamination. VetriGel is an oxidized dextran wound dressing that solidifies in situ. VetriGel is considered a device and is, as such, unregulated by the FDA/CVM. In vivo antibiotic release studies show prolonged levels of antibiotic 1.5 cm away from the site of VetriGel implantation. This observation explains the efficacy of VetriGel in treating a wide range of localized infections. VetriGel has been used extensively in horses and is being used in dogs.